Pharmaceuticals, Biotechnology and Life Sciences
SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced…
WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second…
DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative…
Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuriaSAN DIEGO,…
REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a…
SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…
Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market EntryFREMONT, Calif., Aug. 21, 2024…
TARRYTOWN, N.Y., Aug. 20, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and…
NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company,…
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced…